Retatrutide... A weight-loss drug with record results and risks still under study

Lebanon 24: The weight-loss drug sector has been witnessing rapid development since the discovery of the ability of “GLP-1” drugs to achieve notable weight loss. Among injectable drugs, such as “semaglutide” and “tirzepatide,” and ongoing efforts to develop new treatments, the drug “ريتاتروتايد” (Retatrutide) has emerged as one…
Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.

